A pediatric endocrinologist outlines how clinicians can diagnose and treat growth hormone deficiency earlier in children.

Dr. Chelsea Dorsey discusses CVI as a debilitating, underdiagnosed disease with high costs and limited treatments.

Cheryl Matter, PhD, discusses an AI decision support tool that can improve prostate cancer treatment. She also emphasizes the collaborative effort required across healthcare teams to bring new ...

A medical cartoon by DT Walsh showing a couple discussing getting kicked out of weight class because the husband ate the pie ...

Alex McDonald, MD, is joined by Elizabeth McNeil of the California Medical Association, and together they unpack H. R. 1’s sweeping healthcare cuts, coverage losses, and payment ...

Dr. Ming Tai-Seale discusses the effectiveness of various interventions used to improve primary care clinician-patient ...

The FDA is revising the labeling of all extended-release ADHD medications to warn about adverse reactions in young children.

Dr. Linda Girgis explains the importance of DEI initiatives in the medical sector and offers physicians strategies for advancing DEI in their own practices.

Both patients with IPF and patients with PPF treated with nerandomilast demonstrated a smaller decline in forced vital capacity over 52 weeks versus placebo.

Recent data from a randomized, treat-to-target study show that upadacitinib, a Janus kinase (JAK) inhibitor, offers flexibility in dosing to help patients with moderate-to-severe atopic dermatitis ...

IL-6 blockades with tocilizumab did not improve short-term survival in advanced pancreatic cancer but showed potential anticachexia benefits and improved 18-month survival despite increased toxicity.

APEX shows Tremfya is the first IL-23 inhibitor to slow joint damage in psoriatic arthritis, offering early, multi-domain treatment with lasting benefits.